Showing 721-730 of 1093 results for "".
- Galderma Rolls Out Restylane Refyne, Defynehttps://modernaesthetics.com/news/galderma-rolls-out-restylane-refyne-defyne/2472262/With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --
- Allergan Agrees to Acquire ZELTIQ for $2.47 Billionhttps://modernaesthetics.com/news/allergan-agrees-to-acquire-zeltiq-for-247-billion/2472280/Allergan plc and ZELTIQ® Aesthetics, Inc. have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary
- FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers for “Laugh Lines”https://modernaesthetics.com/news/fda-approves-restylane-refyne-and-restylane-defyne-dermal-fillers-for-laugh-lines/2472303/The FDA has approved two new Galderma products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21. Restylane Refyne was approved for the treatment of moderate to severe facial wrinkles and folds and Restylane®
- Study: CINDR of Masseter Muscle Optimal Injection Site for Botoxhttps://modernaesthetics.com/news/study-cindr-of-masseter-muscle-optimal-injection-site-for-botox/2475664/Research published in the Annals of Anatomy journal indicates the center of the intramuscular nerve dense region (CINDR) of the masseter muscle as the optimal botulinum neurotoxin A (BoNT-A) injection site. The researchers used 60 rabbits to assess BoNT-A injection efficacy at the CINDR.<
- LevEllis Launches Regenerative Serum Featuring Skin-Specific Secretome Technologyhttps://modernaesthetics.com/news/levellis-launches-regenerative-serum-featuring-skin-specific-secretome-technology/2475660/LevEllis, Inc. announced the launch of PROVOQUE™, a physician-dispensed regenerative skincare serum formulated with a proprietary skin-specific secretome. Developed by surgeon and molecular biologist Laura Ellis, MD, the product represents a new approach in medical-grade skincare by delivering a
- New Research Evaluates Nonsurgical Rhinoplasty Using HA Filler in Asian Patientshttps://modernaesthetics.com/news/new-research-evaluates-nonsurgical-rhinoplasty-using-ha-filler-in-asian-patients/2475629/Newly published data in the Plastic and Aesthetic Nursing journal indicates the anatomical and procedural nuances that are critical for achieving optimal results in nonsurgical rhinoplasty (NSR) using hyaluronic acid (HA) dermal filler. Authors Jovian Wan, MBChB, and Kyu-Ho Yi, MD, PhD,
- Sinclair North America Introduces Inaugural Advisory Boardhttps://modernaesthetics.com/news/sinclair-north-america-introduces-inaugural-advisory-board/2475577/Sinclair North America announced its inaugural Advisory Board, consisting of 16 plastic surgeons, dermatologists, aesthetic practitioners, and aestheticians. The board will advance Sinclair North America’s mission of delivering a timeless and trending portfolio of clinically-validated prod
- KeraFactor Launches Dual-Wavelength Laser Cap for At-Home Hair Rejuvenationhttps://modernaesthetics.com/news/kerafactor-launches-dual-wavelength-laser-cap-for-at-home-hair-rejuvenation/2475388/KeraFactor recently announced the release of the KeraFlex Duo, a dual-wavelength laser cap designed to support at-home hair rejuvenation by targeting multiple levels of the scalp, according
- Aesthetic Management Partners Launches New Non-Surgical Skin Revitalization Systemhttps://modernaesthetics.com/news/aesthetic-management-partners-launches-new-non-surgical-skin-revitalization-system/2475387/Aesthetic Management Partners announced the launch of PLADUOpro, a dual argon and nitrogen gas plasma system designed for advanced skin restoration, earlier this month.
- Galderma Establishes new US Headquarters in Florida to Strengthen Regional Leadershiphttps://modernaesthetics.com/news/galderma-establishes-new-us-headquarters-in-florida-to-strengthen-regional-leadership/2475385/Galderma announced Tuesday the company is establishing a new US headquarters in Miami, Florida. The new location aims to position Galderma at the heart of a thriving market for Dermatological Skincare and Injectable Aesthetics. The headquarter will be in the Brickell neighborhood